Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride
Authors:
- 1 October 2017
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 179, 254-259
Abstract
No abstract availableKeywords
Funding Information
- US Food and Drug Administration
- Center for Tobacco Products
This publication has 43 references indexed in Scilit:
- Evaluation of P-glycoprotein (abcb1a/b) modulation of [18F]fallypride in MicroPET imaging studiesNeuropharmacology, 2013
- Distinct Contributions of Dopamine in the Dorsolateral Striatum and Nucleus Accumbens Shell to the Reinforcing Properties of CocaineNeuropsychopharmacology, 2011
- Nonhuman Primate Positron Emission Tomography Neuroimaging in Drug Abuse ResearchThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology SocietyBehavioural Pharmacology, 2010
- The interactive effects of ketamine and nicotine on human cerebral blood flowPsychopharmacology, 2010
- Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaineBrain Research, 2007
- Dopamine, learning and motivationNature Reviews Neuroscience, 2004
- High Levels of Dopamine Activity in the Basal Ganglia of Cigarette SmokersAmerican Journal of Psychiatry, 2000
- Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracerNuclear Medicine and Biology, 1995
- Regional blood flow in canine brain during nicotine infusion: effect of autonomic blocking drugs.Stroke, 1983